Leveraging artificial intelligence-powered stochastic methods for clinical data review represents a significant leap beyond ...

Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota ...

IgniteData is committed to scaling its EHR-to-EDC automation across global research sites, further advancing clinical trial innovation. Insights gained from each deployment will continue to refine and ...

H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from ...

It's unclear what's next for 23andMe, but experts say there's a big incentive for corporations and researchers alike to get ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Billions of clinical insights—once buried in an unusable format—may now be used to train large language models and inform clinical research studies.

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...

In February 2024, Puma initiated ALISCA™-Lung1, a Phase II clinical trial of alisertib monotherapy for the treatment of patients with extensive-stage small cell lung cancer. In November 2024 ...

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that clinical data on neratinib will be presented at the American Association for Cancer Research (AACR) Annual ...

Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...

NEW YORK--(BUSINESS WIRE)--Datavant, the leading health data platform company, today announced the launch of the Datavant Clinical Insights Platform, an integrated offering that empowers health ...